Global CAR-T Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 107 pages | ID: G6FEEA204FB7EN
LP Information

Abstracts

According to this study, the global CAR-T Therapy market size will reach US$ million by 2031.

United States market for CAR-T Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for CAR-T Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for CAR-T Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key CAR-T Therapy players cover Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “CAR-T Therapy Industry Forecast” looks at past sales and reviews total world CAR-T Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected CAR-T Therapy sales for 2025 through 2031. With CAR-T Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Therapy industry.

This Insight Report provides a comprehensive analysis of the global CAR-T Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-T Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-T Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• CD19
• CD22
• Other

Segmentation by Application:

• Acute Lymphocytic Leukemia
• Diffuse Large B Cell Lymphoma
• Follicular Lymphoma
• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis AG
• Kite Pharma
• Pfizer
• Juno Therapeutics
• Celgene Corporation
• CARsgen Therapeutics
• Sorrento Therapeutics
• Legend Biotech
• Atara Biotherapeutics
• Aurora Biopharma
• Autolus Therapeutics PLC
• Bluebird
• Carina Biotech

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CAR-T Therapy Market Size (2020-2031)
  2.1.2 CAR-T Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for CAR-T Therapy by Country/Region (2020, 2024 & 2031)
2.2 CAR-T Therapy Segment by Type
  2.2.1 CD19
  2.2.2 CD22
  2.2.3 Other
2.3 CAR-T Therapy Market Size by Type
  2.3.1 CAR-T Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global CAR-T Therapy Market Size Market Share by Type (2020-2025)
2.4 CAR-T Therapy Segment by Application
  2.4.1 Acute Lymphocytic Leukemia
  2.4.2 Diffuse Large B Cell Lymphoma
  2.4.3 Follicular Lymphoma
  2.4.4 Chronic Lymphocytic Leukemia
  2.4.5 Multiple Myeloma
  2.4.6 Other
2.5 CAR-T Therapy Market Size by Application
  2.5.1 CAR-T Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global CAR-T Therapy Market Size Market Share by Application (2020-2025)

3 CAR-T THERAPY MARKET SIZE BY PLAYER

3.1 CAR-T Therapy Market Size Market Share by Player
  3.1.1 Global CAR-T Therapy Revenue by Player (2020-2025)
  3.1.2 Global CAR-T Therapy Revenue Market Share by Player (2020-2025)
3.2 Global CAR-T Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CAR-T THERAPY BY REGION

4.1 CAR-T Therapy Market Size by Region (2020-2025)
4.2 Global CAR-T Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas CAR-T Therapy Market Size Growth (2020-2025)
4.4 APAC CAR-T Therapy Market Size Growth (2020-2025)
4.5 Europe CAR-T Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa CAR-T Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas CAR-T Therapy Market Size by Country (2020-2025)
5.2 Americas CAR-T Therapy Market Size by Type (2020-2025)
5.3 Americas CAR-T Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC CAR-T Therapy Market Size by Region (2020-2025)
6.2 APAC CAR-T Therapy Market Size by Type (2020-2025)
6.3 APAC CAR-T Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe CAR-T Therapy Market Size by Country (2020-2025)
7.2 Europe CAR-T Therapy Market Size by Type (2020-2025)
7.3 Europe CAR-T Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CAR-T Therapy by Region (2020-2025)
8.2 Middle East & Africa CAR-T Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa CAR-T Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CAR-T THERAPY MARKET FORECAST

10.1 Global CAR-T Therapy Forecast by Region (2026-2031)
  10.1.1 Global CAR-T Therapy Forecast by Region (2026-2031)
  10.1.2 Americas CAR-T Therapy Forecast
  10.1.3 APAC CAR-T Therapy Forecast
  10.1.4 Europe CAR-T Therapy Forecast
  10.1.5 Middle East & Africa CAR-T Therapy Forecast
10.2 Americas CAR-T Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market CAR-T Therapy Forecast
  10.2.2 Canada Market CAR-T Therapy Forecast
  10.2.3 Mexico Market CAR-T Therapy Forecast
  10.2.4 Brazil Market CAR-T Therapy Forecast
10.3 APAC CAR-T Therapy Forecast by Region (2026-2031)
  10.3.1 China CAR-T Therapy Market Forecast
  10.3.2 Japan Market CAR-T Therapy Forecast
  10.3.3 Korea Market CAR-T Therapy Forecast
  10.3.4 Southeast Asia Market CAR-T Therapy Forecast
  10.3.5 India Market CAR-T Therapy Forecast
  10.3.6 Australia Market CAR-T Therapy Forecast
10.4 Europe CAR-T Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market CAR-T Therapy Forecast
  10.4.2 France Market CAR-T Therapy Forecast
  10.4.3 UK Market CAR-T Therapy Forecast
  10.4.4 Italy Market CAR-T Therapy Forecast
  10.4.5 Russia Market CAR-T Therapy Forecast
10.5 Middle East & Africa CAR-T Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market CAR-T Therapy Forecast
  10.5.2 South Africa Market CAR-T Therapy Forecast
  10.5.3 Israel Market CAR-T Therapy Forecast
  10.5.4 Turkey Market CAR-T Therapy Forecast
10.6 Global CAR-T Therapy Forecast by Type (2026-2031)
10.7 Global CAR-T Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market CAR-T Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis AG
  11.1.1 Novartis AG Company Information
  11.1.2 Novartis AG CAR-T Therapy Product Offered
  11.1.3 Novartis AG CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis AG Main Business Overview
  11.1.5 Novartis AG Latest Developments
11.2 Kite Pharma
  11.2.1 Kite Pharma Company Information
  11.2.2 Kite Pharma CAR-T Therapy Product Offered
  11.2.3 Kite Pharma CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Kite Pharma Main Business Overview
  11.2.5 Kite Pharma Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer CAR-T Therapy Product Offered
  11.3.3 Pfizer CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Juno Therapeutics
  11.4.1 Juno Therapeutics Company Information
  11.4.2 Juno Therapeutics CAR-T Therapy Product Offered
  11.4.3 Juno Therapeutics CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Juno Therapeutics Main Business Overview
  11.4.5 Juno Therapeutics Latest Developments
11.5 Celgene Corporation
  11.5.1 Celgene Corporation Company Information
  11.5.2 Celgene Corporation CAR-T Therapy Product Offered
  11.5.3 Celgene Corporation CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Celgene Corporation Main Business Overview
  11.5.5 Celgene Corporation Latest Developments
11.6 CARsgen Therapeutics
  11.6.1 CARsgen Therapeutics Company Information
  11.6.2 CARsgen Therapeutics CAR-T Therapy Product Offered
  11.6.3 CARsgen Therapeutics CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 CARsgen Therapeutics Main Business Overview
  11.6.5 CARsgen Therapeutics Latest Developments
11.7 Sorrento Therapeutics
  11.7.1 Sorrento Therapeutics Company Information
  11.7.2 Sorrento Therapeutics CAR-T Therapy Product Offered
  11.7.3 Sorrento Therapeutics CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Sorrento Therapeutics Main Business Overview
  11.7.5 Sorrento Therapeutics Latest Developments
11.8 Legend Biotech
  11.8.1 Legend Biotech Company Information
  11.8.2 Legend Biotech CAR-T Therapy Product Offered
  11.8.3 Legend Biotech CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Legend Biotech Main Business Overview
  11.8.5 Legend Biotech Latest Developments
11.9 Atara Biotherapeutics
  11.9.1 Atara Biotherapeutics Company Information
  11.9.2 Atara Biotherapeutics CAR-T Therapy Product Offered
  11.9.3 Atara Biotherapeutics CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Atara Biotherapeutics Main Business Overview
  11.9.5 Atara Biotherapeutics Latest Developments
11.10 Aurora Biopharma
  11.10.1 Aurora Biopharma Company Information
  11.10.2 Aurora Biopharma CAR-T Therapy Product Offered
  11.10.3 Aurora Biopharma CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Aurora Biopharma Main Business Overview
  11.10.5 Aurora Biopharma Latest Developments
11.11 Autolus Therapeutics PLC
  11.11.1 Autolus Therapeutics PLC Company Information
  11.11.2 Autolus Therapeutics PLC CAR-T Therapy Product Offered
  11.11.3 Autolus Therapeutics PLC CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Autolus Therapeutics PLC Main Business Overview
  11.11.5 Autolus Therapeutics PLC Latest Developments
11.12 Bluebird
  11.12.1 Bluebird Company Information
  11.12.2 Bluebird CAR-T Therapy Product Offered
  11.12.3 Bluebird CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Bluebird Main Business Overview
  11.12.5 Bluebird Latest Developments
11.13 Carina Biotech
  11.13.1 Carina Biotech Company Information
  11.13.2 Carina Biotech CAR-T Therapy Product Offered
  11.13.3 Carina Biotech CAR-T Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Carina Biotech Main Business Overview
  11.13.5 Carina Biotech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. CAR-T Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CAR-T Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CD19
Table 4. Major Players of CD22
Table 5. Major Players of Other
Table 6. CAR-T Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global CAR-T Therapy Market Size by Type (2020-2025) & ($ millions)
Table 8. Global CAR-T Therapy Market Size Market Share by Type (2020-2025)
Table 9. CAR-T Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global CAR-T Therapy Market Size by Application (2020-2025) & ($ millions)
Table 11. Global CAR-T Therapy Market Size Market Share by Application (2020-2025)
Table 12. Global CAR-T Therapy Revenue by Player (2020-2025) & ($ millions)
Table 13. Global CAR-T Therapy Revenue Market Share by Player (2020-2025)
Table 14. CAR-T Therapy Key Players Head office and Products Offered
Table 15. CAR-T Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global CAR-T Therapy Market Size by Region (2020-2025) & ($ millions)
Table 19. Global CAR-T Therapy Market Size Market Share by Region (2020-2025)
Table 20. Global CAR-T Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global CAR-T Therapy Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas CAR-T Therapy Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas CAR-T Therapy Market Size Market Share by Country (2020-2025)
Table 24. Americas CAR-T Therapy Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas CAR-T Therapy Market Size Market Share by Type (2020-2025)
Table 26. Americas CAR-T Therapy Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas CAR-T Therapy Market Size Market Share by Application (2020-2025)
Table 28. APAC CAR-T Therapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC CAR-T Therapy Market Size Market Share by Region (2020-2025)
Table 30. APAC CAR-T Therapy Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC CAR-T Therapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe CAR-T Therapy Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe CAR-T Therapy Market Size Market Share by Country (2020-2025)
Table 34. Europe CAR-T Therapy Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe CAR-T Therapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa CAR-T Therapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa CAR-T Therapy Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa CAR-T Therapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of CAR-T Therapy
Table 40. Key Market Challenges & Risks of CAR-T Therapy
Table 41. Key Industry Trends of CAR-T Therapy
Table 42. Global CAR-T Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global CAR-T Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global CAR-T Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global CAR-T Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Novartis AG Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 47. Novartis AG CAR-T Therapy Product Offered
Table 48. Novartis AG CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Novartis AG Main Business
Table 50. Novartis AG Latest Developments
Table 51. Kite Pharma Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 52. Kite Pharma CAR-T Therapy Product Offered
Table 53. Kite Pharma CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Kite Pharma Main Business
Table 55. Kite Pharma Latest Developments
Table 56. Pfizer Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 57. Pfizer CAR-T Therapy Product Offered
Table 58. Pfizer CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Pfizer Main Business
Table 60. Pfizer Latest Developments
Table 61. Juno Therapeutics Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 62. Juno Therapeutics CAR-T Therapy Product Offered
Table 63. Juno Therapeutics CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Juno Therapeutics Main Business
Table 65. Juno Therapeutics Latest Developments
Table 66. Celgene Corporation Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 67. Celgene Corporation CAR-T Therapy Product Offered
Table 68. Celgene Corporation CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Celgene Corporation Main Business
Table 70. Celgene Corporation Latest Developments
Table 71. CARsgen Therapeutics Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 72. CARsgen Therapeutics CAR-T Therapy Product Offered
Table 73. CARsgen Therapeutics CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. CARsgen Therapeutics Main Business
Table 75. CARsgen Therapeutics Latest Developments
Table 76. Sorrento Therapeutics Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 77. Sorrento Therapeutics CAR-T Therapy Product Offered
Table 78. Sorrento Therapeutics CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Sorrento Therapeutics Main Business
Table 80. Sorrento Therapeutics Latest Developments
Table 81. Legend Biotech Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 82. Legend Biotech CAR-T Therapy Product Offered
Table 83. Legend Biotech CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Legend Biotech Main Business
Table 85. Legend Biotech Latest Developments
Table 86. Atara Biotherapeutics Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 87. Atara Biotherapeutics CAR-T Therapy Product Offered
Table 88. Atara Biotherapeutics CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Atara Biotherapeutics Main Business
Table 90. Atara Biotherapeutics Latest Developments
Table 91. Aurora Biopharma Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 92. Aurora Biopharma CAR-T Therapy Product Offered
Table 93. Aurora Biopharma CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Aurora Biopharma Main Business
Table 95. Aurora Biopharma Latest Developments
Table 96. Autolus Therapeutics PLC Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 97. Autolus Therapeutics PLC CAR-T Therapy Product Offered
Table 98. Autolus Therapeutics PLC CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Autolus Therapeutics PLC Main Business
Table 100. Autolus Therapeutics PLC Latest Developments
Table 101. Bluebird Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 102. Bluebird CAR-T Therapy Product Offered
Table 103. Bluebird CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Bluebird Main Business
Table 105. Bluebird Latest Developments
Table 106. Carina Biotech Details, Company Type, CAR-T Therapy Area Served and Its Competitors
Table 107. Carina Biotech CAR-T Therapy Product Offered
Table 108. Carina Biotech CAR-T Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Carina Biotech Main Business
Table 110. Carina Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. CAR-T Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CAR-T Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CAR-T Therapy Sales Market Share by Country/Region (2024)
Figure 8. CAR-T Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CAR-T Therapy Market Size Market Share by Type in 2024
Figure 10. CAR-T Therapy in Acute Lymphocytic Leukemia
Figure 11. Global CAR-T Therapy Market: Acute Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 12. CAR-T Therapy in Diffuse Large B Cell Lymphoma
Figure 13. Global CAR-T Therapy Market: Diffuse Large B Cell Lymphoma (2020-2025) & ($ millions)
Figure 14. CAR-T Therapy in Follicular Lymphoma
Figure 15. Global CAR-T Therapy Market: Follicular Lymphoma (2020-2025) & ($ millions)
Figure 16. CAR-T Therapy in Chronic Lymphocytic Leukemia
Figure 17. Global CAR-T Therapy Market: Chronic Lymphocytic Leukemia (2020-2025) & ($ millions)
Figure 18. CAR-T Therapy in Multiple Myeloma
Figure 19. Global CAR-T Therapy Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 20. CAR-T Therapy in Other
Figure 21. Global CAR-T Therapy Market: Other (2020-2025) & ($ millions)
Figure 22. Global CAR-T Therapy Market Size Market Share by Application in 2024
Figure 23. Global CAR-T Therapy Revenue Market Share by Player in 2024
Figure 24. Global CAR-T Therapy Market Size Market Share by Region (2020-2025)
Figure 25. Americas CAR-T Therapy Market Size 2020-2025 ($ millions)
Figure 26. APAC CAR-T Therapy Market Size 2020-2025 ($ millions)
Figure 27. Europe CAR-T Therapy Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa CAR-T Therapy Market Size 2020-2025 ($ millions)
Figure 29. Americas CAR-T Therapy Value Market Share by Country in 2024
Figure 30. United States CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC CAR-T Therapy Market Size Market Share by Region in 2024
Figure 35. APAC CAR-T Therapy Market Size Market Share by Type (2020-2025)
Figure 36. APAC CAR-T Therapy Market Size Market Share by Application (2020-2025)
Figure 37. China CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. India CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe CAR-T Therapy Market Size Market Share by Country in 2024
Figure 44. Europe CAR-T Therapy Market Size Market Share by Type (2020-2025)
Figure 45. Europe CAR-T Therapy Market Size Market Share by Application (2020-2025)
Figure 46. Germany CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. France CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. UK CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa CAR-T Therapy Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa CAR-T Therapy Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa CAR-T Therapy Market Size Market Share by Application (2020-2025)
Figure 54. Egypt CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries CAR-T Therapy Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 60. APAC CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 61. Europe CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 63. United States CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 64. Canada CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 65. Mexico CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 66. Brazil CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 67. China CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 68. Japan CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 69. Korea CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 71. India CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 72. Australia CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 73. Germany CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 74. France CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 75. UK CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 76. Italy CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 77. Russia CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 78. Egypt CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 79. South Africa CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 80. Israel CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 81. Turkey CAR-T Therapy Market Size 2026-2031 ($ millions)
Figure 82. Global CAR-T Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global CAR-T Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries CAR-T Therapy Market Size 2026-2031 ($ millions)